AstraZeneca Invests $2B in Miami Cancer Drug Developer
AstraZeneca has made a significant investment of $2 billion in a Miami-based cancer drug developer. This investment aims to launch clinical trials for specific cancer treatments, marking a major step forward in the fight against cancer in the region.
Ask Maya about this · Get a personalized feed · Continue on WhatsApp